BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jończyk-Matysiak E, Łusiak-Szelachowska M, Kłak M, Bubak B, Międzybrodzki R, Weber-Dąbrowska B, Żaczek M, Fortuna W, Rogóż P, Letkiewicz S, Szufnarowski K, Górski A. The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes. J Immunol Res 2015;2015:482863. [PMID: 26783541 DOI: 10.1155/2015/482863] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sweere JM, Van Belleghem JD, Ishak H, Bach MS, Popescu M, Sunkari V, Kaber G, Manasherob R, Suh GA, Cao X, de Vries CR, Lam DN, Marshall PL, Birukova M, Katznelson E, Lazzareschi DV, Balaji S, Keswani SG, Hawn TR, Secor PR, Bollyky PL. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 2019;363:eaat9691. [PMID: 30923196 DOI: 10.1126/science.aat9691] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 46.0] [Reference Citation Analysis]
2 Śliwka P, Ochocka M, Skaradzińska A. Applications of bacteriophages against intracellular bacteria. Crit Rev Microbiol 2021;:1-18. [PMID: 34428105 DOI: 10.1080/1040841X.2021.1960481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka M, Łusiak-Szelachowska M, Górski A. Bacteriophage Procurement for Therapeutic Purposes. Front Microbiol 2016;7:1177. [PMID: 27570518 DOI: 10.3389/fmicb.2016.01177] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
4 Zhang L, Sun L, Wei R, Gao Q, He T, Xu C, Liu X, Wang R. Intracellular Staphylococcus aureus Control by Virulent Bacteriophages within MAC-T Bovine Mammary Epithelial Cells. Antimicrob Agents Chemother 2017;61:e01990-16. [PMID: 27919889 DOI: 10.1128/AAC.01990-16] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [Reference Citation Analysis]
5 Roach DR, Debarbieux L. Phage therapy: awakening a sleeping giant. Emerg Top Life Sci 2017;1:93-103. [PMID: 33525818 DOI: 10.1042/ETLS20170002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 4] [Article Influence: 11.4] [Reference Citation Analysis]
6 Cieślik M, Bagińska N, Jończyk-Matysiak E, Węgrzyn A, Węgrzyn G, Górski A. Temperate Bacteriophages-The Powerful Indirect Modulators of Eukaryotic Cells and Immune Functions. Viruses 2021;13:1013. [PMID: 34071422 DOI: 10.3390/v13061013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kalapala YC, Sharma PR, Agarwal R. Antimycobacterial Potential of Mycobacteriophage Under Disease-Mimicking Conditions. Front Microbiol 2020;11:583661. [PMID: 33381088 DOI: 10.3389/fmicb.2020.583661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dery KJ, Górski A, Międzybrodzki R, Farmer DG, Kupiec-Weglinski JW. Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation. Transplantation 2021;105:1449-58. [PMID: 33273319 DOI: 10.1097/TP.0000000000003565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hill C, Mills S, Ross RP. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback? Future Microbiol 2018;13:711-26. [PMID: 29792526 DOI: 10.2217/fmb-2017-0261] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
10 Putra RD, Lyrawati D. Interactions between Bacteriophages and Eukaryotic Cells. Scientifica (Cairo) 2020;2020:3589316. [PMID: 32582449 DOI: 10.1155/2020/3589316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Żaczek M, Górski A, Skaradzińska A, Łusiak-szelachowska M, Weber-dąbrowska B. Phage penetration of eukaryotic cells: practical implications. Future Virology 2019;14:745-60. [DOI: 10.2217/fvl-2019-0110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kabwe M, Dashper S, Bachrach G, Tucci J. Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response? FEMS Microbiol Rev 2021:fuab017. [PMID: 33765142 DOI: 10.1093/femsre/fuab017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 De Jode M, Debarbieux L. [Pseudomonas aeruginosa uses its filamentous bacteriophages to manipulate the immune system]. Med Sci (Paris) 2019;35:828-30. [PMID: 31845870 DOI: 10.1051/medsci/2019161] [Reference Citation Analysis]
14 Kabwe M, Meehan-Andrews T, Ku H, Petrovski S, Batinovic S, Chan HT, Tucci J. Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System. Front Microbiol 2021;12:650849. [PMID: 33868210 DOI: 10.3389/fmicb.2021.650849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rogóż P, Amanatullah DF, Międzybrodzki R, Manasherob R, Tikunova NV, Weber-dąbrowska B, Fortuna W, Letkiewicz S, Górski A. Phage Therapy in Orthopaedic Implant-Associated Infections. In: Górski A, Międzybrodzki R, Borysowski J, editors. Phage Therapy: A Practical Approach. Cham: Springer International Publishing; 2019. pp. 189-211. [DOI: 10.1007/978-3-030-26736-0_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J. The Potential of Phage Therapy in Sepsis. Front Immunol 2017;8:1783. [PMID: 29312312 DOI: 10.3389/fimmu.2017.01783] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
17 Górski A, Dąbrowska K, Międzybrodzki R, Weber-Dąbrowska B, Łusiak-Szelachowska M, Jończyk-Matysiak E, Borysowski J. Phages and immunomodulation. Future Microbiol 2017;12:905-14. [PMID: 28434234 DOI: 10.2217/fmb-2017-0049] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
18 Yan W, Banerjee P, Xu M, Mukhopadhyay S, Ip M, Carrigy NB, Lechuga-Ballesteros D, To KKW, Leung SSY. Formulation strategies for bacteriophages to target intracellular bacterial pathogens. Adv Drug Deliv Rev 2021;:113864. [PMID: 34271022 DOI: 10.1016/j.addr.2021.113864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cho Y, Mitchell R, Paudel S, Feltham T, Schon L, Zhang Z. Compromised Antibacterial Function of Multipotent Stromal Cells in Diabetes. Stem Cells and Development 2019;28:268-77. [DOI: 10.1089/scd.2018.0219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Kakasis A, Panitsa G. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int J Antimicrob Agents 2019;53:16-21. [PMID: 30236954 DOI: 10.1016/j.ijantimicag.2018.09.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 17.5] [Reference Citation Analysis]
21 Jończyk-Matysiak E, Weber-Dąbrowska B, Owczarek B, Międzybrodzki R, Łusiak-Szelachowska M, Łodej N, Górski A. Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics. Viruses 2017;9:E150. [PMID: 28613272 DOI: 10.3390/v9060150] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
22 Freyberger HR, He Y, Roth AL, Nikolich MP, Filippov AA. Effects of Staphylococcus aureus Bacteriophage K on Expression of Cytokines and Activation Markers by Human Dendritic Cells In Vitro. Viruses 2018;10:E617. [PMID: 30413044 DOI: 10.3390/v10110617] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Van Belleghem JD, Dąbrowska K, Vaneechoutte M, Barr JJ, Bollyky PL. Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System. Viruses 2018;11:E10. [PMID: 30585199 DOI: 10.3390/v11010010] [Cited by in Crossref: 107] [Cited by in F6Publishing: 75] [Article Influence: 26.8] [Reference Citation Analysis]
24 Secor PR, Burgener EB, Kinnersley M, Jennings LK, Roman-Cruz V, Popescu M, Van Belleghem JD, Haddock N, Copeland C, Michaels LA, de Vries CR, Chen Q, Pourtois J, Wheeler TJ, Milla CE, Bollyky PL. Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections. Front Immunol 2020;11:244. [PMID: 32153575 DOI: 10.3389/fimmu.2020.00244] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
25 Cafora M, Brix A, Forti F, Loberto N, Aureli M, Briani F, Pistocchi A. Phages as immunomodulators and their promising use as anti-inflammatory agents in a cftr loss-of-function zebrafish model. J Cyst Fibros 2020:S1569-1993(20)30927-9. [PMID: 33298374 DOI: 10.1016/j.jcf.2020.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Rubalskii E, Ruemke S, Salmoukas C, Boyle EC, Warnecke G, Tudorache I, Shrestha M, Schmitto JD, Martens A, Rojas SV, Ziesing S, Bochkareva S, Kuehn C, Haverich A. Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery. Antibiotics (Basel) 2020;9:E232. [PMID: 32380707 DOI: 10.3390/antibiotics9050232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
27 Jariah ROA, Hakim MS. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy. Rev Med Virol 2019;29:e2055. [PMID: 31145517 DOI: 10.1002/rmv.2055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Górski A, Międzybrodzki R, Weber-Dąbrowska B, Fortuna W, Letkiewicz S, Rogóż P, Jończyk-Matysiak E, Dąbrowska K, Majewska J, Borysowski J. Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases. Front Microbiol 2016;7:1515. [PMID: 27725811 DOI: 10.3389/fmicb.2016.01515] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 13.8] [Reference Citation Analysis]